Search
Menu
Deposition Sciences Inc. - Difficult Coatings - LB - 8/23

Linden Buys Hycor from Agilent

Facebook X LinkedIn Email
CHICAGO & SANTA CLARA, Calif., Feb. 9, 2010 - Linden LLC, a Chicago-based health care private equity firm, has purchased Hycor Biomedical Inc. from Agilent Technologies for an undisclosed amount. Hycor, located in Garden Grove, Calif., manufactures in vitro diagnostic products for the global allergy, autoimmune and urinalysis markets. Agilent origianlly bought Hycor through its 2007 acquisition of Stratagene. “We believe Hycor has great opportunities outside of the Agilent portfolio,” said Nick Roelofs, president of Agilent’s Life Sciences Group. “Hycor is an innovative, profitable and growing business, but it does not fit...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: February 2010
    Agilent TechnologiesallergyautoimmunityBiophotonicsBusinessCaliforniadiagnosticsEmploymentGarden GroveHycor BiomedicalIllinoisin vitroLaboratory Corporation of AmericaLindenNick RoelofsRichard NovakStratageneurinalysis

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.